Lonza Acquires Zyentia’s Aggresolve Technology

August 21, 2007
BioPharm International Editors

Lonza (Basel, Switzerland, www.lonza.com) purchased Zyentia's (Cambridge, UK, www.zyentia.com) Aggresolve technology, a comprehensive in silico protein analysis platform that can be applied to problem solving of protein aggregation, for an undisclosed sum.

Lonza (Basel, Switzerland, www.lonza.com) purchased Zyentia’s (Cambridge, UK, www.zyentia.com) Aggresolve technology, a comprehensive in silico protein analysis platform that can be applied to problem solving of protein aggregation, for an undisclosed sum.

Aggresolve can be used to screen proteins to predict aggregation problems, to predict sequence changes likely to reduce aggregation, and to design aggregation inhibitors and stabilizers. The technology will be incorporated into a new group headed by Jesus Zurdo, PhD, one of the inventors of the technology.

Related Content:

News | Mergers and Acquisitions